--- title: "TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day" type: "News" locale: "en" url: "https://longbridge.com/en/news/294419780.md" description: "TherapeuticsMD Inc. (TXMD) shares fell 1.46% to $2.03 on Thursday, underperforming the broader market as the NASDAQ rose 2.78%. Despite the decline, TXMD outperformed competitor AbbVie, which dropped 2.24%. The stock remains 31.19% below its 52-week high of $2.95. Trading volume was significantly lower than the 50-day average." datetime: "2026-07-30T21:31:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294419780.md) - [en](https://longbridge.com/en/news/294419780.md) - [zh-HK](https://longbridge.com/zh-HK/news/294419780.md) generator: "portal-rs" --- # TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of TherapeuticsMD Inc. (TXMD) slid 1.46% to $2.03 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.78% to 25,122.18 and the Dow Jones Industrial Average rising 1.19% to 52,208.06. TherapeuticsMD Inc. closed 31.19% below its 52-week high of $2.95, which the company reached on January 27th. Despite its losses, the stock outperformed some of its competitors Thursday, as AbbVie Inc. (ABBV) fell 2.24% to $257.41. Trading volume (14,081) remained 28,714 below its 50-day average volume of 42,795. Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 07-30-26 1731ET ### Related Stocks - [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md) - [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) - [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md) ## Related News & Research - [TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/298771973.md) - [TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors](https://longbridge.com/en/news/297235672.md) - [Apnimed, Inc. reports Q2 results](https://longbridge.com/en/news/298366495.md) - [Braveheart Bio, Inc. reports Q2 results](https://longbridge.com/en/news/298361396.md) - [Beacon Investment Advisory Services Inc. Has $169,000 Position in Kenvue Inc. $KVUE](https://longbridge.com/en/news/298558214.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**